» Articles » PMID: 38369675

Investigating the Combined Toxicity of Cu(II) and Carbon Monoxide (CO); Cellular CO Delivery Using a Cu(II) Flavonolato Complex

Overview
Journal ChemMedChem
Specialties Chemistry
Pharmacology
Date 2024 Feb 18
PMID 38369675
Authors
Affiliations
Soon will be listed here.
Abstract

Carbon monoxide (CO) delivery molecules are of significant current interest as potential therapeutics, including for anticancer applications. A recent approach toward generating new types of materials-based anticancer agents involves combining the Fenton reactivity of a redox active metal ion with CO delivery. However, small molecule examples of these types of entities have not been systematically studied to evaluate the combined effect on cellular toxicity. Herein we describe a Cu(II) flavonolato complex which produces anticancer effects through a combination of copper-mediated reactive oxygen species (ROS) generation and light-induced flavonol CO release. Confocal microscopy studies provide evidence of enhanced flavonol uptake in the copper flavonolato system relative to the free flavonol, which leads to an increased amount of CO delivery within cells. Importantly, this work demonstrates that a metal flavonolato species can be used to produce enhanced toxicity effects resulting from both metal ion-induced Fenton reactivity and increased cellular uptake of a flavonol CO donor.

References
1.
Opoku-Damoah Y, Zhang R, Ta H, Xu Z . Therapeutic gas-releasing nanomedicines with controlled release: Advances and perspectives. Exploration (Beijing). 2023; 2(5):20210181. PMC: 10190986. DOI: 10.1002/EXP.20210181. View

2.
Southam H, Williamson M, Chapman J, Lyon R, Trevitt C, Henderson P . 'Carbon-Monoxide-Releasing Molecule-2 (CORM-2)' Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial Effects. Antioxidants (Basel). 2021; 10(6). PMC: 8227206. DOI: 10.3390/antiox10060915. View

3.
Lyon R, Southam H, Trevitt C, Liao C, El-Khamisy S, Poole R . CORM-3 induces DNA damage through Ru(II) binding to DNA. Biochem J. 2022; 479(13):1429-1439. PMC: 9342897. DOI: 10.1042/BCJ20220254. View

4.
Das N, Bora B, Upadhyay A, Das D, Bera A, Goswami T . Cu(II) flavonoids as potential photochemotherapeutic agents. Dalton Trans. 2024; 53(7):3316-3329. DOI: 10.1039/d3dt02663a. View

5.
Sristi , Fatima M, Sheikh A, Almalki W, Talegaonkar S, Dubey S . Recent advancement on albumin nanoparticles in treating lung carcinoma. J Drug Target. 2023; 31(5):486-499. DOI: 10.1080/1061186X.2023.2205609. View